{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:59:05Z","timestamp":1771660745272,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T00:00:00Z","timestamp":1188518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1752-0509-1-40","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T18:13:27Z","timestamp":1188584007000},"source":"Crossref","is-referenced-by-count":11,"title":["Epstein-Barr virus latency switch in human B-cells: a physico-chemical model"],"prefix":"10.1186","volume":"1","author":[{"given":"Maria","family":"Werner","sequence":"first","affiliation":[]},{"given":"Ingemar","family":"Ernberg","sequence":"additional","affiliation":[]},{"given":"JieZhi","family":"Zou","sequence":"additional","affiliation":[]},{"given":"Jenny","family":"Almqvist","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Aurell","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,8,31]]},"reference":[{"key":"40_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004, 4: 757-768. 10.1038\/nrc1452","journal-title":"Nat Rev Cancer"},{"key":"40_CR2","volume-title":"PhD thesis, Karolinska Institutet","author":"J Almqvist","year":"2005","unstructured":"Almqvist J: Epstein-Barr virus nuclear antigen 1, Oct & Groucho\/TLE in control of promoter regulation. PhD thesis, Karolinska Institutet. 2005"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/rmv.456","volume":"15","author":"W Amon","year":"2005","unstructured":"Amon W, Farrell PJ: Reactivation of Epstein-Barr virus from latency. Reviews in Medical Virology. 2005, 15: 149-156. 10.1002\/rmv.456","journal-title":"Reviews in Medical Virology"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","volume":"10","author":"ER Leight","year":"2000","unstructured":"Leight ER, Sugden B: EBNA-1: a protein pivotal to latent infection bt Epsein-barr virus. Reviews in Medical Virology. 2000, 10: 83-100. 10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","journal-title":"Reviews in Medical Virology"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1073\/pnas.88.15.6550","volume":"88","author":"BC Schaefer","year":"1991","unstructured":"Schaefer BC, Woisetschlager M, Strominger JL, Speck SH: Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitts lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci. 1991, 88: 6550-6554. 10.1073\/pnas.88.15.6550","journal-title":"Proc Natl Acad Sci"},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/MCB.17.1.364","volume":"17","author":"BC Schaefer","year":"1997","unstructured":"Schaefer BC, Strominger JL, Speck SH: Host-cell-determined methylation of specific Epstein-Barr virus promoter regulates the choice between distinct viral latency programs. Molecular and Cellular Biology. 1997, 17: 364-377.","journal-title":"Molecular and Cellular Biology"},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1099\/0022-1317-80-2-457","volume":"80","author":"H Zetterberg","year":"1999","unstructured":"Zetterberg H, Stenglein M, Jansson A, Ricksten A, Rymo L: Relative levels of EBNA1 gene transcripts from the C\/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection. Journal of General Virology. 1999, 80: 457-465.","journal-title":"Journal of General Virology"},{"key":"40_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/dna.1995.14.767","volume":"14","author":"CN Tsai","year":"1995","unstructured":"Tsai CN, Liu ST, Chang YS: Identification of a novel promoter located within the BamHIQ region of the Epstein-barr virus genome for the EBNA 1 gene. DNA and Cell Biology. 1995, 14: 767-776.","journal-title":"DNA and Cell Biology"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.71.1.354-361.1997","volume":"71","author":"C Nonkwelo","year":"1997","unstructured":"Nonkwelo C, Ruf IK, Sample J: The Epstein-Barr virus EBNA-1 promoter Qp requires an intitator-like element. Journal of Virology. 1997, 71: 354-361.","journal-title":"Journal of Virology"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/JVI.61.11.3424-3430.1987","volume":"61","author":"M Bodescot","year":"1987","unstructured":"Bodescot M, Perricaudet M, Farrell PJ: A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. Journal of Virology. 1987, 61: 3424-3430.","journal-title":"Journal of Virology"},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1099\/vir.0.80620-0","volume":"86","author":"J Almqvist","year":"2005","unstructured":"Almqvist J, Zou J, Linderson Y, Borestrom C, Altiok E, Zetterberg H, Rymo L, Petterson S, Ernberg I: Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus ori P. Journal of General Virology. 2005, 86: 1261-1267. 10.1099\/vir.0.80620-0","journal-title":"Journal of General Virology"},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1128\/MCB.6.11.3838","volume":"6","author":"D Reisman","year":"1986","unstructured":"Reisman D, Sugden B: Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Molecular and Cellular Biology. 1986, 6: 3838-3846.","journal-title":"Molecular and Cellular Biology"},{"key":"40_CR13","first-page":"2644","volume":"73","author":"B Sugden","year":"1999","unstructured":"Sugden B, Warren N: A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA repliction during latent infection. Journal of Virology. 1999, 73: 2644-2649.","journal-title":"Journal of Virology"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1128\/JVI.63.6.2657-2666.1989","volume":"63","author":"DA Wysokenski","year":"1989","unstructured":"Wysokenski DA, Yates JL: Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. Journal of Virology. 1989, 63: 2657-2666.","journal-title":"Journal of Virology"},{"key":"40_CR15","first-page":"693","volume":"25","author":"H Zetterberg","year":"2004","unstructured":"Zetterberg H, Borestrom C, Nilsson T, Rymo L: Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. International Journal of Oncolocy. 2004, 25: 693-696.","journal-title":"International Journal of Oncolocy"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1093\/nar\/gki744","volume":"33","author":"S Malin","year":"2005","unstructured":"Malin S, Linderson Y, Almqvist J, Ernberg I, Tallone T, Petterson S: DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho\/TLE. Nucleic Acids Research. 2005, 33: 4618-4625. 10.1093\/nar\/gki744","journal-title":"Nucleic Acids Research"},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/JVI.65.5.2164-2169.1991","volume":"65","author":"NS Sung","year":"1991","unstructured":"Sung NS, Kenney S, Gutch D, Pagano JS: EBNA-2 transcativates a lymphoid-specific enhancer in the Bam HI C promoter of Epstein-Barr virus. Journal of Virology. 1991, 65: 2164-2169.","journal-title":"Journal of Virology"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1073\/pnas.90.20.9237","volume":"90","author":"PD Ling","year":"1993","unstructured":"Ling PD, Rawlins DR, Hayward SD: The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci. 1993, 90: 9237-9241. 10.1073\/pnas.90.20.9237","journal-title":"Proc Natl Acad Sci"},{"key":"40_CR19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/JVI.64.5.1984-1990.1990","volume":"64","author":"SR Kupfer","year":"1990","unstructured":"Kupfer SR, Summers WC: Identification of a Glucocorticoid-responsive element in Epstein-Barr virus. Journal of Virology. 1990, 64: 1984-1990.","journal-title":"Journal of Virology"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1128\/JVI.75.13.5796-5811.2001","volume":"75","author":"T Nilsson","year":"2001","unstructured":"Nilsson T, Zetterberg H, Wang YC, Rymo L: Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. Journal of Virology. 2001, 75: 5796-5811. 10.1128\/JVI.75.13.5796-5811.2001","journal-title":"Journal of Virology"},{"key":"40_CR21","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/JVI.70.9.5758-5768.1996","volume":"70","author":"MT Puglielli","year":"1996","unstructured":"Puglielli MT, Woisetschlaeger M, Speck SH: oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Journal of Virology. 1996, 70: 5758-5768.","journal-title":"Journal of Virology"},{"key":"40_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-1119(99)00180-8","volume":"234","author":"K Roder","year":"1999","unstructured":"Roder K, Wolf S, Larkin K, Schweizer M: Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene. 1999, 234: 61-69. 10.1016\/S0378-1119(99)00180-8","journal-title":"Gene"},{"issue":"1","key":"40_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1529\/biophysj.106.099929","volume":"93","author":"RF Guerra","year":"2007","unstructured":"Guerra RF, Imperadori L, Mantovani R, Dunlap DD, Finzi L: DNA compaction by the nuclear factor Y (NF-Y). Biophys J. 2007, 93 (1): 176-182. 10.1529\/biophysj.106.099929","journal-title":"Biophys J"},{"key":"40_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-1119(99)00368-6","volume":"239","author":"R Mantovani","year":"1999","unstructured":"Mantovani R: Review: The molecular biology of the CCAAt-binding factor NF-y. gene. 1999, 239: 15-27. 10.1016\/S0378-1119(99)00368-6","journal-title":"gene"},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"10565","DOI":"10.1073\/pnas.92.23.10565","volume":"92","author":"BC Schaefer","year":"1995","unstructured":"Schaefer BC, Strominger JL, Speck SH: Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci. 1995, 92: 10565-10569. 10.1073\/pnas.92.23.10565","journal-title":"Proc Natl Acad Sci"},{"key":"40_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/MCB.17.2.873","volume":"17","author":"BC Schaefer","year":"1997","unstructured":"Schaefer BC, Paulson E, Strominger JL, Speck SH: Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Molecular and Cellular Biology. 1997, 17: 873-886.","journal-title":"Molecular and Cellular Biology"},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.1128\/MCB.14.11.7144","volume":"14","author":"NS Sung","year":"1994","unstructured":"Sung NS, Wilson J, Davenport M, Sista ND, Pagano JS: Reciprocal regulation of the Epstein-Barr virus Bam HI-F promoter by EBNA-1 and an E2F transcription factor. Molecular and Cellular Biology. 1994, 14: 7144-7152.","journal-title":"Molecular and Cellular Biology"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1128\/JVI.73.10.7943-7951.1999","volume":"73","author":"IK Ruf","year":"1999","unstructured":"Ruf IK, Sample J: Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency. Journal of Virology. 1999, 73: 7943-7951.","journal-title":"Journal of Virology"},{"key":"40_CR29","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.66.8.4654-4661.1992","volume":"66","author":"J Sample","year":"1992","unstructured":"Sample J, Henson EB, Sample C: The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol. 1992, 66: 4654-4661.","journal-title":"J Virol"},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-2836(85)90086-5","volume":"181","author":"M Shea","year":"1985","unstructured":"Shea M, Ackers G: The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. J Mol Biol. 1985, 181: 211-230. 10.1016\/0022-2836(85)90086-5","journal-title":"J Mol Biol"},{"key":"40_CR31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.gde.2005.02.007","volume":"15","author":"L Bintu","year":"2005","unstructured":"Bintu L, Buchler NE, Garcia HG, Gerland U, Hwa T, Kondev J, Kuhlman T, Phillips R: Transcriptional regulation by the numbers: models. Curr Opin Genet Dev. 2005, 15: 116-124. 10.1016\/j.gde.2005.02.007","journal-title":"Curr Opin Genet Dev"},{"key":"40_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0022-5193(05)80111-0","volume":"145","author":"J Reinitz","year":"1990","unstructured":"Reinitz J, Vaisnys JR: Theoretical and experimental analysis of the phage lambda genetic switch implies missing levels of co-operativity. Journal of Theoretical Biology. 1990, 145: 295-318.","journal-title":"Journal of Theoretical Biology"},{"key":"40_CR33","doi-asserted-by":"publisher","first-page":"051914","DOI":"10.1103\/PhysRevE.65.051914","volume":"65","author":"E Aurell","year":"2002","unstructured":"Aurell E, Brown S, Johanson J, Sneppen K: Stability puzzles in phage lambda. Physical Review E. 2002, 65: 051914-051914. 10.1103\/PhysRevE.65.051914.","journal-title":"Physical Review E"},{"key":"40_CR34","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1128\/JVI.75.6.2584-2596.2001","volume":"75","author":"D Salamon","year":"2001","unstructured":"Salamon D, Takacs M, Ujvari D, Uhlig J, Wolf H, Minarovits J, Niller HH: Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p pf Epstein-Barr virus. J Virol. 2001, 75: 2584-2596. 10.1128\/JVI.75.6.2584-2596.2001","journal-title":"J Virol"},{"key":"40_CR35","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1128\/JVI.00025-06","volume":"80","author":"CM Chau","year":"2006","unstructured":"Chau CM, Zhang XY, McMahon SB, Lieberman PM: Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol. 2006, 80: 5723-5732. 10.1128\/JVI.00025-06","journal-title":"J Virol"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/nar\/29.7.1410","volume":"29","author":"H Brantjes","year":"2001","unstructured":"Brantjes H, Roose J, van De Wetering M, Clevers H: All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res. 2001, 29: 1410-1419. 10.1093\/nar\/29.7.1410","journal-title":"Nucleic Acids Res"},{"key":"40_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ijc.10417","volume":"99","author":"K Pokrovskaja","year":"2002","unstructured":"Pokrovskaja K, Ehlin-Henriksson B, Kiss C, Challa A, Gordon J, Gogolak P, Klein G, Szekely L: CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines. Int J Cancer. 2002, 99: 705-712. 10.1002\/ijc.10417","journal-title":"Int J Cancer"},{"key":"40_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","volume":"132","author":"M Hong","year":"2006","unstructured":"Hong M, Murai Y, Kutsuna T, Takahashi H, Nomoto K, ans Shin Ishizawa CMC, Zhao QL, Ogawa R, Harmon BV, Tsuneyama K, Takano Y: Suppression of Epstein-barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. Journal of Cancer Research and Clinical Oncology. 2006, 132: 1-8. 10.1007\/s00432-005-0036-x.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/JVI.64.5.2369-2379.1990","volume":"64","author":"RF Ambinder","year":"1990","unstructured":"Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD: Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. Journal of Virology. 1990, 64: 2369-2379.","journal-title":"Journal of Virology"},{"key":"40_CR40","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1016\/S0021-9258(20)89523-4","volume":"266","author":"L Frappier","year":"1991","unstructured":"Frappier L, O'Donnell M: Overproduction, purification and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. The Journal of Biological Chemistry. 1991, 266: 7819-1826.","journal-title":"The Journal of Biological Chemistry"},{"key":"40_CR41","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1093\/emboj\/16.23.7105","volume":"16","author":"PC Shah","year":"1997","unstructured":"Shah PC, Bertolino E, Singh H: Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. The EMBO Journal. 1997, 16: 7105-7117. 10.1093\/emboj\/16.23.7105","journal-title":"The EMBO Journal"},{"key":"40_CR42","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1002\/j.1460-2075.1992.tb05606.x","volume":"11","author":"C Verrijzer","year":"1992","unstructured":"Verrijzer C, Alkema M, van Weperen W, Leeuwen HV, Strating M, van der Vliet P: The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 1992, 11: 4993-5003.","journal-title":"EMBO J"},{"key":"40_CR43","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1128\/JVI.64.5.2407-2410.1990","volume":"64","author":"L Sternas","year":"1990","unstructured":"Sternas L, Middleton T, Sugden B: The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol. 1990, 64: 2407-2410.","journal-title":"J Virol"},{"key":"40_CR44","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.73.4.3154-3161.1999","volume":"73","author":"MG Davenport","year":"1999","unstructured":"Davenport MG, Pagano JS: Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. Journal of Virology. 1999, 73: 3154-3161.","journal-title":"Journal of Virology"},{"key":"40_CR45","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J Levitskaya","year":"1997","unstructured":"Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG: Inhibition of ubiquitin\/proteasome-dependent protein degradation by hte Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA. 1997, 94: 12616-12621. 10.1073\/pnas.94.23.12616","journal-title":"Proc Natl Acad Sci USA"},{"key":"40_CR46","first-page":"591","volume":"13","author":"KB Woo","year":"1980","unstructured":"Woo KB, Funkhouser WK, Sullivan C, Alabaster O: Analysis of the proliferation kinetics of Burkitt's lymphoma cells. Cell Tissue Kinteics. 1980, 13: 591-604.","journal-title":"Cell Tissue Kinteics"},{"key":"40_CR47","doi-asserted-by":"publisher","first-page":"54817","DOI":"10.1074\/jbc.M405911200","volume":"279","author":"T Daikoku","year":"2004","unstructured":"Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Tsurumi T: In vivo dynamics of EBNA-oriP interaction during latent and lytic replication of Epstein-Barr virus. Journal of Biological Chemistry. 2004, 279: 54817-54825. 10.1074\/jbc.M405911200","journal-title":"Journal of Biological Chemistry"},{"key":"40_CR48","volume-title":"Cellular and molecular immunology","author":"AK Abbas","year":"2000","unstructured":"Abbas AK, Lichtman AH, Pober JS: Cellular and molecular immunology. 2000, Philadelphia: W.B. Saunders Company"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-1-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-0509-1-40\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-1-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T16:49:04Z","timestamp":1629650944000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-1-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,31]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-1-40","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,31]]},"article-number":"40"}}